Bristol-Myers Squibb Co - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
BMY New York 2834 https://www.bms.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Bristol-Myers Squibb Co

Bristol Myers Squibb Receives Positive CHMP Opinion for CAR T Cell Therapy Breyanzi (lisocabtagene maraleucel) for Relapsed or Refractory Large B-cell Lymphoma After One Prior Therapy - Mar 31st, 2023 12:07 pm
Bristol Myers' Flagship Opdivo Shows Long Term Durable Benefits In Lung Cancer Patients - Mar 30th, 2023 6:18 pm
Bristol-Myers Squibb Company (NYSE:BMY) is a favorite amongst institutional investors who own 77% - Mar 30th, 2023 2:00 pm
Neoadjuvant Opdivo (nivolumab) with Chemotherapy Demonstrates Long-Term, Durable Clinical Benefits for Patients with Resectable Non-Small Cell Lung Cancer at Three Years in the CheckMate -816 Trial - Mar 30th, 2023 1:10 pm
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises - Mar 30th, 2023 1:00 pm
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings - Mar 29th, 2023 1:00 pm
Bristol Myers Squibb (BMY) Gains As Market Dips: What You Should Know - Mar 28th, 2023 9:50 pm
Bristol Myers (BMY) Gets Approval of Psoriasis Drug in EU - Mar 28th, 2023 7:22 pm
Could This Drug Candidate Be a Winner for These 2 Big Pharma Stocks? - Mar 28th, 2023 2:15 pm
Is Eli Lilly or Bristol Myers Squibb the Better Value Stock to Buy Right Now? - Mar 28th, 2023 2:15 pm
Bristol Myers Squibb Receives European Commission Approval of Sotyktu (deucravacitinib), a Once-Daily Oral Treatment for Adults With Moderate-to-Severe Plaque Psoriasis - Mar 28th, 2023 10:59 am
Iovance (IOVA) Completes Rolling BLA Filing for Melanoma Drug - Mar 27th, 2023 3:35 pm
Bristol Myers Squibb (BMY) Stock Moves -0.4%: What You Should Know - Mar 22nd, 2023 9:50 pm
Takeda's Highest Dose Psoriasis Candidate Can Potentially Beat Bristol Myers' Approved Drug, Analyst Says - Mar 20th, 2023 4:21 pm
Bristol-Myers Squibb (NYSE:BMY) Seems To Use Debt Quite Sensibly - Mar 20th, 2023 12:00 pm
2 Top Healthcare Stocks to Buy for the Long Haul - Mar 17th, 2023 2:15 pm
Bristol Myers Squibb (BMY) Stock Sinks As Market Gains: What You Should Know - Mar 16th, 2023 9:50 pm
Got $5,000? These 2 High-Yielding Dividend Stocks Are Near Their 52-Week Lows - Mar 16th, 2023 1:15 pm
Bristol Myers Squibb Announces Progress Toward Long-Term Inclusion & Diversity Goals and Health Equity Commitments - Mar 15th, 2023 10:59 am
Best-Selling Drugs by Bristol Myers, Pfizer, AbbVie Likely Candidates For US Price Negotiation - Mar 13th, 2023 7:18 pm